• 1
    Schmitt JA. Nutrition and cognition: meeting the challenge to obtain credible and evidence-based facts. Nutr Rev. 2010;68(Suppl 1):S2S5.
  • 2
    Wesnes KA. Evaluation of techniques to identify beneficial effects of nutrition and natural products on cognitive function. Nutr Rev. 2010;68(Suppl 1):S22S28.
  • 3
    Dye L, Lluch A, Blundell JE. Macronutrients and mental performance. Nutrition. 2000;16:10211034.
  • 4
    Benton D, Kallus KW, Schmitt JA. How should we measure nutrition-induced improvements in memory? Eur J Nutr. 2005;44:485498.
  • 5
    Wesnes KA, Brooker H. Pharmacodynamic evaluation: CNS. In: Vogel HG , Maas J , Gebauer A , eds. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Berlin: Springer Verlag; 2010.
  • 6
    Dangour AD, Allen E, Richards M, et al. Design considerations in long-term intervention studies for the prevention of cognitive decline or dementia. Nutr Rev. 2010;68(Suppl 1):S16S21.
  • 7
    de Jager CA, Kovatcheva A. Summary and discussion: methodologies to assess long-term effects of nutrition on brain function. Nutr Rev. 2010;68(Suppl 1):S53S58.
  • 8
    de Vries J, Antoine JM, Chiodini A, et al. Markers for nutrition studies: review of criteria for the evaluation of markers. Eur J Nutr. 2013;52:16851699.
  • 9
    Paus T. A primer for brain imaging: a tool for evidence-based studies of nutrition? Nutr Rev. 2010;68(Suppl 1):S29S37.
  • 10
    Robbins TW, James M, Owen AM, et al. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia. 1994;5:266281.
  • 11
    Simpson PM, Wesnes K, Christmas L. A computerized system for the assessment of drug-induced performance changes in young elderly or demented populations. Br J Clin Pharmacol. 1989;27:711712.
  • 12
    Wesnes KA. An automated system for assessing cognitive function in any environment. Society of PhotoOptical Instrumentation Engineers (SPIE) Conference Series. Proc SPIE. 2005;5797:2441.
  • 13
    Maruff P, Thomas E, Cysique L, et al. Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex. Arch Clin Neuropsychol. 2009;24:165178.
  • 14
    Wesnes KA, Pincock C, Richardson D, et al. Breakfast reduces declines in attention and memory over the morning in schoolchildren. Appetite. 2003;41:329331.
  • 15
    Wesnes KA, Pincock C, Scholey A. Breakfast is associated with enhanced cognitive function in schoolchildren: an internet based study. Appetite. 2012;59:646649.
  • 16
    Yurko-Mauro K, McCarthy D, Rom D, et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010;6:456464.
  • 17
    Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet. 2007;369:208216.
  • 18
    Eussen SJ, de Groot LC, Joosten LW, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84:361370.
  • 19
    Kang JH, Cook N, Manson J, et al. A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. Am J Clin Nutr. 2008;88:16021610.
  • 20
    Obied R, Fink-Geisel U, Eckert R, et al. Effect of the B-vitamins on cognitive function in elderly people with mild cognitive dysfunction. Clin Chem Lab Med. 2005;43:A1A36.
  • 21
    Krikorian R, Nash TA, Shidler MD, et al. Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. Br J Nutr. 2010;103:730734.
  • 22
    Krikorian R, Shidler MD, Nash TA, et al. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010;58:39964000.
  • 23
    Dangour AD, Allen E, Elbourne D, et al. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr. 2010;91:17251732.
  • 24
    Geleijnse JM, Giltay EJ, Kromhout D. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients. Alzheimers Dement. 2012;8:278287.
  • 25
    Ho SC, Chan AS, Ho YP, et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007;14(3 Pt 1):489499.
  • 26
    Kreijkamp-Kaspers S, Kok L, Grobbee DE, et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004;292:6574.
  • 27
    Stott DJ, MacIntosh G, Lowe GD, et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr. 2005;82:13201326.
  • 28
    McMahon JA, Green TJ, Skeaff CM, et al. A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006;354:27642772.
  • 29
    Gleason CE, Carlsson CM, Barnet JH, et al. A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing. 2009;38:8693.
  • 30
    Fioravanti M, Ferrario E, Massaia M, et al. Low folate levels in the cognitive decline of elderly patients and the efficacy of folate as a treatment for improving memory deficits. Arch Gerontol Geriatr. 1998;26:113.
  • 31
    Crews WD Jr, Harrison DW, Griffin ML, et al. A double-blinded, placebo-controlled, randomized trial of the neuropsychologic efficacy of cranberry juice in a sample of cognitively intact older adults: pilot study findings. J Altern Complement Med. 2005;11:305309.
  • 32
    Crews WD Jr, Harrison DW, Wright JW. A double-blind, placebo-controlled, randomized trial of the effects of dark chocolate and cocoa on variables associated with neuropsychological functioning and cardiovascular health: clinical findings from a sample of healthy, cognitively intact older adults. Am J Clin Nutr. 2008;87:872880.
  • 33
    Bryan J, Calvaresi E, Hughes D. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. J Nutr. 2002;132:13451356.
  • 34
    File SE, Jarrett N, Fluck E, et al. Eating soya improves human memory. Psychopharmacology (Berl). 2001;157:430436.
  • 35
    File SE, Hartley DE, Elsabagh S, et al. Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause. 2005;12:193201.
  • 36
    Howes JB, Bray K, Lorenz L, et al. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric. 2004;7:7077.
  • 37
    Kritz-Silverstein D, Von Mühlen D, Barrett-Connor E, et al. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003;10:196202.
  • 38
    Sommer BR, Hoff AL, Costa M. Folic acid supplementation in dementia: a preliminary report. J Geriatr Psychiatry Neurol. 2003;16:156159.
  • 39
    Ryan J, Croft K, Mori T, et al. An examination of the effects of the antioxidant Pycnogenol on cognitive performance, serum lipid profile, endocrinological and oxidative stress biomarkers in an elderly population. J Psychopharmacol. 2008;22:553562.
  • 40
    Vanata DF, Metzger MM. Acute soy isoflavone consumption does not impact visual-spatial or verbal memory among healthy young adults. N Am J Psychol. 2007;9:379386.
  • 41
    Baumgartner J, Smuts CM, Malan L, et al. Effects of iron and n-3 fatty acid supplementation, alone and in combination, on cognition in school children: a randomized, double-blind, placebo-controlled intervention in South Africa. Am J Clin Nutr. 2012;96:13271338.
  • 42
    Lee LK, Shahar S, Chin AV, et al. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology (Berl). 2013;225:605612.
  • 43
    de Jager CA, Oulhaj A, Jacoby R, et al. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012;27:592600.
  • 44
    Deijen JB, van der Beek EJ, Orlebeke JF, et al. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berl). 1992;109:489496.
  • 45
    Fournier LR, Ryan Borchers TA, Robison LM, et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging. 2007;11:155164.
  • 46
    Pipingas A, Silberstein RB, Vitetta L, et al. Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract formulation. Phytother Res. 2008;22:11681174.
  • 47
    Kennedy DO, Jackson PA, Elliott JM, et al. Cognitive and mood effects of 8 weeks’ supplementation with 400 mg or 1000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10–12 years. Nutr Neurosci. 2009;12:4856.
  • 48
    Lewerin C, Matousek M, Steen G, et al. Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study. Am J Clin Nutr. 2005;81:11551162.
  • 49
    Basaria S, Wisniewski A, Dupree K, et al. Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women. J Endocrinol Invest. 2009;32:150155.
  • 50
    Thorp AA, Sinn N, Buckley JD, et al. Soya isoflavone supplementation enhances spatial working memory in men. Br J Nutr. 2009;102:13481354.
  • 51
    Field DT, Williams CM, Butler LT. Consumption of cocoa flavanols results in an acute improvement in visual and cognitive functions. Physiol Behav. 2011;103:255260.
  • 52
    Richardson AJ, Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics. 2005;115:13601366.
  • 53
    Duffy R, Wiseman H, File SE. Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003;75:721729.
  • 54
    van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology. 2008;71:430438.
  • 55
    Casini ML, Marelli G, Papaleo E, et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril. 2006;85:972978.
  • 56
    Scholey AB, French SJ, Morris PJ, et al. Consumption of cocoa flavanols results in acute improvements in mood and cognitive performance during sustained mental effort. J Psychopharmacol. 2010;24:15051514.
  • 57
    Hendrickson SJ, Mattes RD. No acute effects of grape juice on appetite, implicit memory and mood. Food Nutr Res. 2008;52. doi:10.3402/fnr.v52i0.1891.
  • 58
    Nilsson A, Radeborg K, Salo I, et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J. 2012;11:99. doi: 10.1186/1475-2891-11-99.
  • 59
    Kennedy DO, Wightman EL, Reay JL, et al. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. Am J Clin Nutr. 2010;91:15901597.
  • 60
    Richardson AJ, Burton JR, Sewell RP, et al. Docosahexaenoic acid for reading, cognition and behavior in children aged 7–9 years: a randomized, controlled trial (the DOLAB Study). PLoS ONE. 2012;7:e43909. doi: 10.1371/journal.pone.0043909.
  • 61
    Walker JG, Batterham PJ, Mackinnon AJ, et al. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms – the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr. 2012;95:194203.
  • 62
    Morris MS. The role of B vitamins in preventing and treating cognitive impairment and decline. Adv Nutr. 2012;3:801812.
  • 63
    Clarke R, Harrison G, Richards S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med. 2003;254:6775.
  • 64
    Hvas AM, Juul S, Lauritzen L, et al. No effect of vitamin B-12 treatment on cognitive function and depression: a randomized placebo controlled study. J Affect Disord. 2004;81:269273.
  • 65
    Seal EC, Metz J, Flicker L, et al. A randomized, double-blind, placebo-controlled study of oral vitamin B12 supplementation in older patients with subnormal or borderline serum vitamin B12 concentrations. J Am Geriatr Soc. 2002;50:146151.
  • 66
    van Asselt DZ, Pasman JW, van Lier HJ, et al. Cobalamin supplementation improves cognitive and cerebral function in older, cobalamin-deficient persons. J Gerontol A Biol Sci Med Sci. 2001;56:M775M779.
  • 67
    Balk EM, Raman G, Tatsioni A, et al. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 2007;167:2130.
  • 68
    Ford AH, Almeida OP. Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials. J Alzheimers Dis. 2012;29:133149.
  • 69
    Karr JE, Grindstaff TR, Alexander JE. Omega-3 polyunsaturated fatty acids and cognition in a college-aged population. Exp Clin Psychopharmacol. 2012;20:236242.
  • 70
    Malouf M, Grimley EJ, Areosa SA. Folic acid with or without vitamin B12 for cognition and dementia. Cochrane Database Syst Rev. 2003;(4):CD004514.
  • 71
    Francis ST, Head K, Morris PG, et al. The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol. 2006;47(Suppl 2):S215S220.
  • 72
    Lezak MD, Howieson DB, Loring DW, et al. Neuropsychological Assessment. Oxford: Oxford University Press; 2004.
  • 73
    Mathias JL, Bowden SC, Bigler ED, et al. Is performance on the Wechsler Test of Adult Reading affected by traumatic brain injury? Br J Clin Psychol. 2007;46(Pt 4):457466.
  • 74
    Tulving E, Thompson DM. Encoding specificity and retrieval processes in episodic memory. Psychol Rev. 1973;80:352373.
  • 75
    Coltheart M. The MRC psycholinguistic database: machine readable dictionary. Q J Exp Psychol. 1981;33A:497505.
  • 76
    Rey A. Examen Clinique en Psychologie. Paris, France: Universitaires de France; 1964.
  • 77
    Delaney RC, Prevey ML, Cramer J, et al. Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures. Arch Clin Neuropsychol. 1992;7:523528.
  • 78
    Macartney-Filgate MS, Vriezen ER. Intercorrelation of clinical tests of verbal memory. Arch Clin Neuropsychol. 1988;3:121126.
  • 79
    Delis DC, Freeland J, Kramer JH, et al. Integrating clinical assessment with cognitive neuroscience: construct validation of the California Verbal Learning Test. J Consult Clin Psychol. 1988;56:123130.
  • 80
    Delis DC, Kaplan E, Kramer JH, et al. California Verbal Learning Test – Second Edition (CVLT-II) Manual. San Antonio, TX: Psychological Corporation; 2000.
  • 81
    Rapport LJ, Axelrod BN, Theisen ME, et al. Relationship of IQ to verbal learning and memory: test and retest. J Clin Exp Neuropsychol. 1997;19:655666.
  • 82
    Schear JM, Craft RB. Examination of the concurrent validity of the California Verbal Learning Test. Clin Neuropsychol. 1989;3:162168.
  • 83
    Brandt J. The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5:125142.
  • 84
    Lacritz LH, Cullum CM, Weiner MF, et al. Comparison of the Hopkins Verbal Learning Test-Revised to the California Verbal Learning Test in Alzheimer's disease. Appl Neuropsychol. 2001;8:180184.
  • 85
    Rasmusson DX, Bylsma FW, Brandt J. Stability of performance on the Hopkins Verbal Learning Test. Arch Clin Neuropsychol. 1995;10:2126.
  • 86
    Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology. 1974;24:10191025.
  • 87
    Larrabee GJ, Levin HS. Memory self-ratings and objective test performance in a normal elderly sample. J Clin Exp Neuropsychol. 1986;8:275284.
  • 88
    Hannay HJ, Levin HS. Selective reminding test: an examination of the equivalence of four forms. J Clin Exp Neuropsychol. 1985;7:251263.
  • 89
    Wechsler D. Wechsler Memory Scale-Revised: Manual. San Antonio, TX: Psychological Corp; 1987.
  • 90
    McCaffrey RJ, Ortega A, Orsillo SM, et al. Practice effects in repeated neuropsychological assessments. Clin Neuropsychol. 1992;6:3242.
  • 91
    Youngjohn JR, Larrabee GJ, Crook TH. Test-retest reliability of computerized, everyday memory measures and traditional memory tests. Clin Neuropsychol. 1992;6:276286.
  • 92
    Wechsler D. Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: Psychological Corporation; 1997.
  • 93
    Hickman SE, Howieson DB, Dame A, et al. Longitudinal analysis of the effects of the aging process on neuropsychological test performance in the healthy young-old and oldest-old. Dev Neuropsychol. 2000;17:323337.
  • 94
    Theisen ME, Rapport LJ, Axelrod BN, et al. Effects of practice in repeated administrations of the Wechsler Memory Scale Revised in normal adults. Assessment. 1998;5:8592.
  • 95
    Woodard JL, Goldstein FC, Roberts VJ, et al. Convergent and discriminant validity of the CVLT (dementia version). California Verbal Learning Test. J Clin Exp Neuropsychol. 1999;21:553558.
  • 96
    Jones EK, Sunram-Lea SI, Wesnes KA. Acute ingestion of different macronutrients differentially enhances aspects of memory and attention in healthy young adults. Biol Psychol. 2012;89:477486.
  • 97
    Wesnes K, Ward T, McGinty A, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology (Berl). 2000;152:353361.
  • 98
    Krikorian R, Boespflug EL, Fleck DE, et al. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem. 2012;60:57365742.
  • 99
    Postma A, Jager G, Kessels RP, et al. Sex differences for selective forms of spatial memory. Brain Cogn. 2004;54:2434.
  • 100
    Velazquez-Zamora DA, Gonzalez-Ramirez MM, Beas-Zarate C, et al. Egocentric working memory impairment and dendritic spine plastic changes in prefrontal neurons after NMDA receptor blockade in rats. Brain Res. 2011;1402:101108.
  • 101
    Baddeley A. Working memory: theories, models, and controversies. Annu Rev Psychol. 2012;63:129.
  • 102
    Miyake A, Friedman NP, Rettinger DA, et al. How are visuospatial working memory, executive functioning, and spatial abilities related? A latent-variable analysis. J Exp Psychol Gen. 2001;130:621640.
  • 103
    Silverman I, Choi J, Mackewn A, et al. Evolved mechanisms underlying wayfinding. Further studies on the hunter-gatherer theory of spatial sex differences. Evol Hum Behav. 2000;21:201213.
  • 104
    Piper BJ, Acevedo SF, Edwards KR, et al. Age, sex, and handedness differentially contribute to neurospatial function on the Memory Island and Novel-Image Novel-Location tests. Physiol Behav. 2011;103:513522.
  • 105
    Kessels RP, Nys GM, Brands AM, et al. The modified Location Learning Test: norms for the assessment of spatial memory function in neuropsychological patients. Arch Clin Neuropsychol. 2006;21:841846.
  • 106
    Mahoney CR, Taylor HA, Kanarek RB, et al. Effect of breakfast composition on cognitive processes in elementary school children. Physiol Behav. 2005;85:635645.
  • 107
    Glahn DC, Gur RC, Ragland JD, et al. Reliability, performance characteristics, construct validity, and an initial clinical application of a visual object learning test (VOLT). Neuropsychology. 1997;11:602612.
  • 108
    Barr WB, Chelune GJ, Hermann BP, et al. The use of figural reproduction tests as measures of nonverbal memory in epilepsy surgery candidates. J Int Neuropsychol Soc. 1997;3:435443.
  • 109
    Millis SR, Malina AC, Bowers DA, et al. Confirmatory factor analysis of the Wechsler Memory Scale-III. J Clin Exp Neuropsychol. 1999;21:8793.
  • 110
    Larrabee GJ, Curtiss G. Construct validity of various verbal and visual memory tests. J Clin Exp Neuropsychol. 1995;17:536547.
  • 111
    Leonberger FT, Nicks SD, Larrabee GJ, et al. Factor structure of the Wechsler Memory Scale–Revised within a comprehensive neuropsychological battery. Neuropsychology. 1992;6:239–249.
  • 112
    Baser CA, Ruff RM. Construct validity of the San Diego Neuropsychological Test Battery. Arch Clin Neuropsychol. 1987;2:1332.
  • 113
    Sunram-Lea SI, Foster JK, Durlach P, et al. Investigation into the significance of task difficulty and divided allocation of resources on the glucose memory facilitation effect. Psychopharmacology (Berl). 2002;160:387397.
  • 114
    Sunram-Lea SI, Foster JK, Durlach P, et al. The influence of fat co-administration on the glucose memory facilitation effect. Nutr Neurosci. 2004;7:2132.
  • 115
    Henderson VW, St John JA, Hodis HN, et al. Long-term soy isoflavone supplementation and cognition in women: a randomized, controlled trial. Neurology. 2012;78:18411848.
  • 116
    Lamport DJ, Dye L, Mansfield MW, et al. Acute glycaemic load breakfast manipulations do not attenuate cognitive impairments in adults with type 2 diabetes. Clin Nutr. 2013;32:265272.
  • 117
    Blundell J, de Graaf C, Hulshof T, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251270.
  • 118
    Santos RF, Galduroz JC, Barbieri A, et al. Cognitive performance, SPECT, and blood viscosity in elderly non-demented people using Ginkgo biloba. Pharmacopsychiatry. 2003;36:127133.
  • 119
    Schubert M, Contreras C, Franz N, et al. Milk-based phospholipids increase morning cortisol availability and improve memory in chronically stressed men. Nutr Res. 2011;31:413420.
  • 120
    Petersen SE, Posner MI. The attention system of the human brain: 20 years after. Annu Rev Neurosci. 2012;35:7389.
  • 121
    Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci. 1990;13:2542.
  • 122
    Oken BS, Salinsky MC, Elsas SM. Vigilance, alertness, or sustained attention: physiological basis and measurement. Clin Neurophysiol. 2006;117:18851901.
  • 123
    Carrasco M. Visual attention: the past 25 years. Vision Res. 2011;51:14841525.
  • 124
    Posner MI. Measuring alertness. Ann N Y Acad Sci. 2008;1129:193199.
  • 125
    Hahn B, Wolkenberg FA, Ross TJ, et al. Divided versus selective attention: evidence for common processing mechanisms. Brain Res. 2008;1215:137145.
  • 126
    Le Fever FF. A noncoding motoric equivalent measures most of what the Digit Symbol does, including age changes. Percept Mot Skills. 1985;61:371377.
  • 127
    Erber JT, Botwinick J, Storandt M. The impact of memory on age differences in Digit Symbol performance. J Gerontol. 1981;36:586590.
  • 128
    Matarazzo JD, Herman DO. Base rate data for the WAIS-R: test-retest stability and VIQ-PIQ differences. J Clin Neuropsychol. 1984;6:351366.
  • 129
    McCaffrey RJ, Duff K, Westervelt HJ. Practitioner's Guide to Evaluating Change with Intellectual Assessment Instruments. New York: Plenum; 2000.
  • 130
    Smilek D, Carriere JS, Cheyne JA. Failures of sustained attention in life, lab, and brain: ecological validity of the SART. Neuropsychologia. 2010;48:25642570.
  • 131
    Borgaro S, Pogge DL, DeLuca VA, et al. Convergence of different versions of the Continuous Performance Test: clinical and scientific implications. J Clin Exp Neuropsychol. 2003;25:283292.
  • 132
    Armstrong CL, Hayes KM, Martin R. Neurocogntive problems in attention deficit disorder. Ann N Y Acad Sci. 2001;931:196215.
  • 133
    Huang-Pollock CL, Karalunas SL, Tam H, et al. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnorm Psychol. 2012;121:360371.
  • 134
    Johnson KA, Kelly SP, Bellgrove MA, et al. Response variability in attention deficit hyperactivity disorder: evidence for neuropsychological heterogeneity. Neuropsychologia. 2007;45:630638.
  • 135
    Manly T, Anderson V, Nimmo-Smith I, et al. The differential assessment of children's attention: the Test of Everyday Attention for Children (TEA-Ch), normative sample and ADHD performance. J Child Psychol Psychiatry. 2001;42:10651081.
  • 136
    Robertson IH, Ward T, Ridgeway V, et al. The structure of normal human attention: the Test of Everyday Attention. J Int Neuropsychol Soc. 1996;2:525534.
  • 137
    Guerreiro MJ, Murphy DR, Van Gerven PW. The role of sensory modality in age-related distraction: a critical review and a renewed view. Psychol Bull. 2010;136:9751022.
  • 138
    McDowd JM. An overview of attention: behavior and brain. J Neurol Phys Ther. 2007;31:98103.
  • 139
    Carriere JS, Cheyne JA, Solman GJ, et al. Age trends for failures of sustained attention. Psychol Aging. 2010;25:569574.
  • 140
    Mani TM, Bedwell JS, Miller LS. Age-related decrements in performance on a brief continuous performance test. Arch Clin Neuropsychol. 2005;20:575586.
  • 141
    Ridderinkhof KR, van der Stelt O. Attention and selection in the growing child: views derived from developmental psychophysiology. Biol Psychol. 2000;54:55106.
  • 142
    Aguiar A, Eubig PA, Schantz SL. Attention deficit/hyperactivity disorder: a focused overview for children's environmental health researchers. Environ Health Perspect. 2010;118:16461653.
  • 143
    Kramer AF, Cepeda NJ, Cepeda ML. Methylphenidate effects on task-switching performance in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2001;40:12771284.
  • 144
    Shalev L, Ben-Simon A, Mevorach C, et al. Conjunctive Continuous Performance Task (CCPT) – a pure measure of sustained attention. Neuropsychologia. 2011;49:25842591.
  • 145
    Ruxton CHS. The impact of caffeine on mood, cognitive function, performance and hydration: a review of benefits and risks. Nutr Bull. 2008;33:1525.
  • 146
    Brunyé TT, Mahoney CR, Lieberman HR, et al. Caffeine modulates attention network function. Brain Cogn. 2010;72:181188.
  • 147
    Foxe JJ, Morie KP, Laud PJ, et al. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task. Neuropharmacology. 2012;62:23202327.
  • 148
    Serra-Grabulosa JM, Adan A, Falcon C, et al. Glucose and caffeine effects on sustained attention: an exploratory fMRI study. Hum Psychopharmacol. 2010;25:543552.
  • 149
    Tieges Z, Snel J, Kok A, et al. Caffeine does not modulate inhibitory control. Brain Cogn. 2009;69:316327.
  • 150
    Schneider W, Shiffrin RM. Controlled and automatic human information processing: I. Detection, search, and attention. Psychol Rev. 1977;84:166.
  • 151
    Donders FC. Die schnelligkeit psychischer prozesse. Archïv für Anatomie und Physiologie. 1868:657681.
  • 152
    Salthouse TA. Cognitive aspects of motor functioning. Ann N Y Acad Sci. 1988;515:3341.
  • 153
    Gronwall DM. Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills. 1977;44:367373.
  • 154
    Feinstein A, Brown R, Ron M. Effects of practice of serial tests of attention in healthy subjects. J Clin Exp Neuropsychol. 1994;16:436447.
  • 155
    Green J, Forster A, Young J. A test-retest reliability study of the Barthel Index, the Rivermead Mobility Index, the Nottingham Extended Activities of Daily Living Scale and the Frenchay Activities Index in stroke patients. Disabil Rehabil. 2001;23:670676.
  • 156
    Gill DM, Reddon JR, Stefanyk WO, et al. Finger tapping: effects of trials and sessions. Percept Mot Skills. 1986;62:675678.
  • 157
    Klove H. Clinical neuropsychology. In: Forster FM , ed. Medical Clinics of North America. New York: Saunders; 1963.
  • 158
    Ingwersen J, Defeyter MA, Kennedy DO, et al. A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining throughout the morning. Appetite. 2007;49:240244.
  • 159
    Taib MN, Shariff ZM, Wesnes KA, et al. The effect of high lactose-isomaltulose on cognitive performance of young children. A double blind cross-over design study. Appetite. 2012;58:8187.
  • 160
    Scholey AB, Kennedy DO. Cognitive and physiological effects of an “energy drink”: an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology (Berl). 2004;176:320330.
  • 161
    Wesnes K, Barrett M, Udani J. Sustained improvements in cognitive function produced by an energy shot in healthy volunteers. J Frailty Aging. 2012;1:7475.
  • 162
    Haskell CF, Kennedy DO, Wesnes KA, et al. Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine. Psychopharmacology (Berl). 2005;179:813825.
  • 163
    Baddeley A. The central executive: a concept and some misconceptions. J Int Neuropsychol Soc. 1998;4:523526.
  • 164
    Leh SE, Petrides M, Strafella AP. The neural circuitry of executive functions in healthy subjects and Parkinson's disease. Neuropsychopharmacology. 2010;35:7085.
  • 165
    Wilson BA, Alderman N, Burgess PW, et al. Behavioural Assessment of the Dysexecutive Syndrome (BADS). San Antonio, TX: Pearson; 2012.
  • 166
    Smith A. Symbol Digit Modalities Test. Los Angeles, CA: Western Psychological Services; 1982.
  • 167
    Welsh MC, Satterlee-Cartmell T, Stine M. Towers of Hanoi and London: contribution of working memory and inhibition to performance. Brain Cogn. 1999;41:231242.
  • 168
    Channon S, Crawford S. Problem-solving in real-life-type situations: the effects of anterior and posterior lesions on performance. Neuropsychologia. 1999;37:757770.
  • 169
    Goel V, Grafman J, Tajik J, et al. A study of the performance of patients with frontal lobe lesions in a financial planning task. Brain. 1997;120(Pt 10):18051822.
  • 170
    Humes GE, Welsh MC, Retzlaff PD, et al. Towers of Hanoi and London: reliability and validity of two executive function tasks. Assessment. 1997;4:249257.
  • 171
    Goel V, Grafman J. Are the frontal lobes implicated in “planning” functions? Interpreting data from the Tower of Hanoi. Neuropsychologia. 1995;33:623642.
  • 172
    Miyake A, Emerson MJ, Friedman NP. Assessment of executive functions in clinical settings: problems and recommendations. Semin Speech Lang. 2000;21:169183.
  • 173
    Miyake A, Friedman NP, Emerson MJ, et al. The unity and diversity of executive functions and their contributions to complex “frontal lobe” tasks: a latent variable analysis. Cogn Psychol. 2000;41:49100.
  • 174
    Goela V, Pullara SD, Grafman J. A computational model of frontal lobe dysfunction: working memory and the Tower of Hanoi task. Cogn Sci. 2001;25:287313.
  • 175
    Bowler R, Sudia S, Mergler D, et al. Comparison of Digit Symbol and Symbol Digit Modalities tests for assessing neurotoxic exposure. Clin Neuropsychol. 1992;6:103104.
  • 176
    Muslimovic D, Post B, Speelman JD, et al. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009;15:426437.
  • 177
    McCaffrey RJ, Ortega A, Haase RF. Effects of repeated neuropsychological assessments. Arch Clin Neuropsychol. 1993;8:519524.
  • 178
    Chester JG, Grande LJ, Milberg WP, et al. Cognitive screening in community-dwelling elders: performance on the Clock-in-the-Box. Am J Med. 2011;124:662669.
  • 179
    Sinn N, Milte CM, Street SJ, et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr. 2012;107:16821693.
  • 180
    Mazereeuw G, Lanctot KL, Chau SA, et al. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012;33:1482.e171482.e29.
  • 181
    Macready AL, Butler LT, Kennedy OB, et al. Cognitive tests used in chronic adult human randomised controlled trial micronutrient and phytochemical intervention studies. Nutr Res Rev. 2010;23:200229.
  • 182
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189198.
  • 183
    Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry. 1984;141:13561364.
  • 184
    Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695699.
  • 185
    Brandt J, Welsh KA, Breitner JC, et al. Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs. Arch Neurol. 1993;50:599603.
  • 186
    Roth M, Tym E, Mountjoy CQ, et al. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986;149:698709.
  • 187
    Letenneur L, Proust-Lima C, Le GA, et al. Flavonoid intake and cognitive decline over a 10-year period. Am J Epidemiol. 2007;165:13641371.
  • 188
    Roselli F, Tartaglione B, Federico F, et al. Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors. Clin Neurol Neurosurg. 2009;111:327330.
  • 189
    Nelson HE. National Adult Reading Test (NART): For the Assessment of Premorbid Intelligence in Patients with Dementia: Test Manual. Windsor, UK: NFER-Nelson; 1982.
  • 190
    Cattell RB. Culture Fair Intelligence Test: A Measure of “G”. Savoy, IL: Institute for Personality and Ability Testing Inc; 1950.
  • 191
    Baron IS. Test review: Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV). Child Neuropsychol. 2005;11:471475.
  • 192
    Deary IJ, Gow AJ, Taylor MD, et al. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr. 2007;7:28. doi:10.1186/1471-2318-7-28.
  • 193
    Cattell RB. Classical and standard score IQ standardization of the I.P.A.T Culture-Free Intelligence Scale 2. J Consult Psychol. 1951;15:154159.
  • 194
    Crawford JR, Stewart LE, Cochrane RH, et al. Estimating premorbid IQ from demographic variables: regression equations derived from a UK sample. Br J Clin Psychol. 1989;28(Pt 3):275278.
  • 195
    Goldstein LH, McNeil JE. Methods for estimating premorbid ability. In: Goldstein LH , McNeil JE , eds. Clinical Neuropsychology: A Practical Guide to Assessment and Management for Clinicians. Chichester, UK: John Wiley & Sons Ltd; 2004:134137.
  • 196
    Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med. 1995;25:12111219.
  • 197
    Brandt J, Folstein SE, Folstein MF. Differential cognitive impairment in Alzheimer's disease and Huntington's disease. Ann Neurol. 1988;23:555561.
  • 198
    de Jager CA, Budge MM, Clarke R. Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry. 2003;18:318324.
  • 199
    Markwick A, Zamboni G, de Jager CA. Profiles of cognitive subtest impairment in the Montreal Cognitive Assessment (MoCA) in a research cohort with normal Mini-Mental State Examination (MMSE) scores. J Clin Exp Neuropsychol. 2012;34:750757.
  • 200
    Sydenham E, Dangour AD, Lim WS. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database Syst Rev. 2012;(6):CD005379.
  • 201
    Rondanelli M, Opizzi A, Faliva M, et al. Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment. Nutr Neurosci. 2012;15:4654.
  • 202
    Hoyland A, Lawton CL, Dye L. Acute effects of macronutrient manipulations on cognitive test performance in healthy young adults: a systematic research review. Neurosci Biobehav Rev. 2008;32:7285.
  • 203
    Lieberman HR. Nutrition, brain function and cognitive performance. Appetite. 2003;40:245254.
  • 204
    Hoyland A, Dye L, Lawton CL. A systematic review of the effect of breakfast on the cognitive performance of children and adolescents. Nutr Res Rev. 2009;22:220243.
  • 205
    Dye L, Blundell J. Functional foods: psychological and behavioural functions. Br J Nutr. 2002;88(Suppl 2):S187S211.